Inventor · disambiguated record
Karl-Heinz Heider
Also filed as: HEIDER KARL-HEINZ
15 granted patents·20 pending applications·173 citations·filing 1994–2022
93Inventor score
Files withBOEHRINGER INGELHEIM INT24HEIDER KARL-HEINZ3ADOLF GUENTHER2STILGENBAUER STEPHAN2BOEHRINGER INGELHEIM PHARMA1
Top patents by PatentIndex Score
35 records- 0188US9078879B2Anti CD37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2013·Granted Jul 14, 2015·7 cites·29 claims
- 0288US7361347B2Cytotoxic CD44 antibody immunoconjugatesBOEHRINGER INGELHEIM INT·Filed 2005·Granted Apr 22, 2008·8 cites·21 claims
- 0387US6972324B2Antibodies specific for CD44v6BOEHRINGER INGELHEIM INT·Filed 2002·Granted Dec 6, 2005·31 cites·68 claims
- 0486US9550833B2CD33 binding agentsBOEHRINGER INGELHEIM INT·Filed 2015·Granted Jan 24, 2017·5 cites·12 claims
- 0585US8992915B2Combination of CD37 antibodies with ICEHEIDER KARL-HEINZ·Filed 2013·Granted Mar 31, 2015·15 cites·23 claims
- 0685US8568727B2Antibody molecules specific for fibroblast activation protein and immunoconjugates containing themADOLF GUENTHER·Filed 2006·Granted Oct 29, 2013·24 cites·15 claims
- 0783US9079958B2CD33 binding agentsKONOPITZKY RENATE·Filed 2011·Granted Jul 14, 2015·8 cites·31 claims
- 0876US6383733B1Methods of screening for pharmacologically active compounds for the treatment of tumour diseasesBOEHRINGER INGELHEIM INT·Filed 1997·Granted May 7, 2002·39 cites·14 claims
- 0975US10202451B2CD33 binding agentsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Feb 12, 2019·1 cites·12 claims
- 1073US9932399B2Anti CD37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 3, 2018·1 cites·10 claims
- 1172US2021230271A1Anti-cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 1267US6372441B1Method for diagnosis and therapy of Hodgkin's lymphomasKARLSRUHE FORSCHZENT·Filed 1997·Granted Apr 16, 2002·17 cites·7 claims
- 1366US2010189722A1Anti cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 1464US2018186876A1Anti cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1560US2019256593A1Cd33 binding agentsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1658US2013236454A1Superior efficacy of cd37 antibodies in cll blood samplesSTILGENBAUER STEPHAN·Filed 2013·Application pending·0 cites
- 1758US2015125447A1Pharmaceutical combinations comprising cd33 antibodies and de-methylating agentsBOEHRINGER INGELHEIM INT·Filed 2014·Application pending·0 cites
- 1857US12275798B2Tri-specific binding moleculesBOEHRINGER INGELHEIM INT·Filed 2022·Granted Apr 15, 2025·0 cites·17 claims
- 1957US2004126379A1Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agentsBOEHRINGER INGELHEIM INT·Filed 2003·Application pending·0 cites
- 2056US2011165153A1Anti cd37 antibodiesBOEHRINGER INGELHEIM INT·Filed 2010·Application pending·0 cites
- 2155US2013287797A1Combination of cd37 antibodies with bendamustineHEIDER KARL-HEINZ·Filed 2013·Application pending·0 cites
- 2255US2005244413A1Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and chemotherapeutic agentsADOLF GUENTHER·Filed 2005·Application pending·0 cites
- 2354US7417127B2Antibodies specific for CD44v6BOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Aug 26, 2008·0 cites·14 claims
- 2454US2012189618A1Superior efficacy of cd37 antibodies in cll blood samplesSTILGENBAUER STEPHAN·Filed 2011·Application pending·0 cites
- 2553US2015266967A1Superior efficacy of cd37 antibodies in cll blood samplesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 2653US2018064811A1Pharmaceutical combinations comprising cd33 antibodies and de-methylating agentsBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 2752US2004120949A1Compositions and methods for treating cancer using cytotoxic CD44 antibody immunoconjugates and radiotherapyBOEHRINGER INGELHEIM INT·Filed 2003·Application pending·0 cites
- 2851US2015231242A1Combination of cd37 antibodies with bendamustineBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 2951US2016106837A1Combination of cd37 antibodies with chlorambucilBOEHRINGER INGELHEIM INT·Filed 2013·Application pending·0 cites
- 3051US2003103985A1Cytotoxic CD44 antibody immunoconjugatesBOEHRINGER INGELHEIM INT·Filed 2002·Application pending·0 cites
- 3148US6010865AProcess for detecting a variant CD44 gene productBOEHRINGER INGELHEIM INT·Filed 1994·Granted Jan 4, 2000·17 cites·7 claims
- 3246US7745585B2Antibodies to interleukin-like epithelial-mesenchymal transition inducer (ILEI)BOEHRINGER INGELHEIM INT·Filed 2004·Granted Jun 29, 2010·0 cites·22 claims
- 3344US2002127542A1Pharmaceutical compositions for treating tumour diseasesBOEHRINGER INGELHEIM INT·Filed 2002·Application pending·0 cites
- 3441US2003032073A1Method for diagnosis and therapy of Hodgkin's lymphomasFiled 2002·Application pending·0 cites
- 3541US2013309224A1Combination of cd37 antibodies with rituximabHEIDER KARL-HEINZ·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karl-Heinz Heider files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →